Acumen Pharmaceuticals (ABOS) Shares Outstanding (Weighted Average) (2020 - 2026)

Acumen Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $63.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 4.45% year-over-year to $63.2 million; the TTM figure through Mar 2026 stood at $63.2 million (up 4.45% YoY), while the FY2025 annual figure was $60.6 million, up 0.91% from the prior year.
• Shares Outstanding (Weighted Average) came in at $63.2 million for Q1 2026 at Acumen Pharmaceuticals, up from $60.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $63.2 million in Q1 2026 to a low of $40.5 million in Q1 2022.
• A 5-year average of $52.5 million and a median of $59.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 16213.22% in 2022 and climbed 0.82% in 2025, its largest moves.
• Acumen Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $40.6 million in 2022, then advanced by 19.72% to $48.6 million in 2023, then increased by 23.46% to $60.0 million in 2024, then climbed by 0.91% to $60.6 million in 2025, then increased by 4.39% to $63.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $63.2 million, $60.6 million, and $60.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison